Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 124 Records) |
Query Trace: Neoplasms and CYP2C19[original query] |
---|
CYP2C19 polymorphism in relation to the pharmacotherapy optimization of commonly used drugs. Die Pharmazie 2018 11 73 (11): 619-624. Sienkiewicz-Oleszkiewicz B, Wiela-Hoje?ska |
Association of breast cancer risk with polymorphisms in genes involved in the metabolism of xenobiotics and interaction with tobacco smoking: A gene-set analysis. International journal of cancer 2019 04 144 (8): 1896-1908. Berrandou Takiy, Mulot Claire, Cordina-Duverger Emilie, Arveux Patrick, Laurent-Puig Pierre, Truong Thérèse, Guénel Pasc |
Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population. BMC medical genetics 2019 Sep 20 (1): 148. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients. Cancers 2019 9 11 (9): . Ahmed Jemal Hussien, Makonnen Eyasu, Fotoohi Alan, Aseffa Abraham, Howe Rawleigh, Aklillu Ele |
CYP2J27 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients. Frontiers in pharmacology 2019 5 10 481. Ahmed Jemal Hussien, Makonnen Eyasu, Yimer Getnet, Seifu Daniel, Bekele Abebe, Assefa Mathewos, Aseffa Abraham, Howe Rawleigh, Fotoohi Alan, Hassan Moustapha, Aklillu Ele |
Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study. Clinical pharmacology and therapeutics 2019 Feb . Puszkiel Alicja, Arellano Cécile, Vachoux Christelle, Evrard Alexandre, Le Morvan Valérie, Boyer Jean-Christophe, Robert Jacques, Delmas Caroline, Dalenc Florence, Debled Marc, Venat-Bouvet Laurence, Jacot William, Suc Etienne, Sillet-Bach Isabelle, Filleron Thomas, Roché Henri, Chatelut Etienne, White-Koning Melanie, Thomas Fabien |
Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2020 6 41 (3): 447-452. Charo Lindsey M, Homer Michael V, Natarajan Loki, Haunschild Carolyn, Chung Karine, Mao Jun J, DeMichele Angela M, Su H Ire |
Model-Based Quantification of Impact of Genetic Polymorphisms and Co-Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer. Clinical pharmacology and therapeutics 2020 Oct . Puszkiel Alicja, Arellano Cécile, Vachoux Christelle, Evrard Alexandre, Le Morvan Valérie, Boyer Jean-Christophe, Robert Jacques, Delmas Caroline, Dalenc Florence, Debled Marc, Venat-Bouvet Laurence, Jacot William, Dohollou Nadine, Bernard-Marty Chantal, Laharie-Mineur Hortense, Filleron Thomas, Roché Henri, Chatelut Etienne, Thomas Fabienne, White-Koning Melan |
Prevalence of five pharmacologically most important CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Srpska in Bosnia and Herzegovina. Arhiv za higijenu rada i toksikologiju 2021 6 72 (3): 129-134. Vidovi? Stojko, Škrbi? Ranko, Stojiljkovi? Miloš P, Vidovi? Vanja, Be?arevi? Jelena, Stoisavljevi?-Šatara Svjetlana, Maksimovi? Ne |
Cytochrome P450 2C19 gene polymorphisms (CYP2C19*2 and CYP2C19*3) in chronic myeloid leukemia patients: in vitro and in silico studies. Journal of biomolecular structure & dynamics 2021 Jun 1-14. Joshi Kaishiv, Kaur Satbir, Kumar Rake |
Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients. Cancer chemotherapy and pharmacology 2021 Jun . Helsby Nuala, Yong Minghan, Burns Kathryn, Findlay Michael, Porter Dav |
The role of phase I, phase II, and DNA-repair gene polymorphisms in the damage induced by formaldehyde in pathologists. Scientific reports 2021 May 11 (1): 10507. Ghelli Federica, Cocchi Enrico, Buglisi Martina, Squillacioti Giulia, Bellisario Valeria, Bono Roberto, Santovito Alfre |
Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population. Pharmaceuticals (Basel, Switzerland) 2021 4 14 (3): . Barnett Shelby, Errington Julie, Sludden Julieann, Jamieson David, Poinsignon Vianney, Paci Angelo, Veal Gareth |
A Population Pharmacokinetic Meta-Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients. Journal of clinical pharmacology 2021 Apr . Stodtmann Sven, Nuthalapati Silpa, Eckert Doerthe, Kasichayanula Sreeneeranj, Joshi Rujuta, Bach Bruce A, Mensing Sven, Menon Rajeev, Xiong H |
Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana |
Enriching Medication Review with a Pharmacogenetic Profile - A Case of Tamoxifen Adverse Drug Reactions. Pharmacogenomics and personalized medicine 2021 14 279-286. Jeiziner Chiara, Stäuble Céline K, Lampert Markus L, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
Pharmacogenomic analysis of a genetically distinct Indigenous population. The pharmacogenomics journal 2021 11 22 (2): 100-108. Jaya Shankar Arvind, Jadhao Sudhir, Hoy Wendy, Foote Simon J, Patel Hardip R, Scaria Vinod, McMorran Brendan J, Nagaraj Shivashankar |
Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse. Scientific reports 2021 Jan 11 (1): 415. Sanchez-Spitman A B, Swen J J, Dezentjé V O, Moes D J A R, Gelderblom H, Guchelaar H |
Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers in pharmacology 2022 13 918219. Tan Tingfei, Han Gongwei, Cheng Ziwei, Jiang Jiemei, Zhang Li, Xia Zitong, Wang Xinmeng, Xia Qu |
Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022 May . Hwang Mary, Medley Sarah, Shakeel Faisal, Vanderwerff Brett, Zawistowski Matthew, Kidwell Kelley M, Hertz Daniel |
Association of CYP2C19 Polymorphism With Proton Pump Inhibitors Effectiveness and With Fractures in Real-Life: Retrospective Cohort Study. Clinical pharmacology and therapeutics 2022 Feb . Gronich Naomi, Lavi Idit, Lejbkowicz Flavio, Pinchev Mila, Rennert G |
Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers. JCO precision oncology 2022 2 6 e2100312. Shugg Tyler, Ly Reynold C, Rowe Elizabeth J, Philips Santosh, Hyder Mustafa A, Radovich Milan, Rosenman Marc B, Pratt Victoria M, Callaghan John T, Desta Zeruesenay, Schneider Bryan P, Skaar Todd |
The formation of SCEs as an effect of occupational exposure to formaldehyde. Archives of toxicology 2022 Feb . Ghelli Federica, Cocchi Enrico, Bellisario Valeria, Buglisi Martina, Squillacioti Giulia, Santovito Alfredo, Bono Rober |
CYP2C19*17 association with higher plasma 4-hydroxy tamoxifen in Pakistani (estrogen-positive) breast cancer patients. Experimental biology and medicine (Maywood, N.J.) 2023 9 15353702231187640. Muhammad Usman Tareen, Sana Riaz, Saima Shakil Malik, Sana Zahid, Anum Khursheed, Fizza Tariq, Faiza Abbas, Muhammad Nouman Malik, Riffat Aysha Anis, Mariam Anees, Iram Murtaza, Aneesa Sult |
Predictive modeling of adverse drug reactions to tamoxifen therapy for breast cancer on base of pharmacogenomic testing. Drug metabolism and personalized therapy 2023 7 . Ekaterina Olegovna Golubenko, Marina Ivanovna Savelyeva, Zhannet Alimovna Sozaeva, Vera Vyacheslavovna Korennaya, Irina Vladimirovna Poddubnaya, Timur Tejmurazovich Valiev, Svetlana Nikolaevna Kondratenko, Mikhail Vitalyevich Ily |
CYP2C19 gene polymorphism in Ningxia. Pharmacological reports : PR 2023 3 . Yang Zhen, Xie Yunqian, Zhang Daya, Zou Yan, Li Ximei, Chen Runxiang, Zhang Xiaodong, Chen Shiju, Bai Fei |
Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients. The pharmacogenomics journal 2023 1 . Gillis Nancy, Etheridge Amy S, Patil Sushant A, Hayes D Neil, Hayward Michele C, Auman J Todd, Parker Joel S, Innocenti Federi |
The Effect of CYP2C19*2 (rs4244285) and CYP17 (rs743572) SNPs on Adriamycin and Paclitaxel based Chemotherapy Outcomes in Breast Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2024 6 25 (6): 1977-1986. Rashmi A Gudur, Suresh J Bhosale, Anand K Gudur, Shivani R Kale, Ashwini L More, Kailas D Datkhi |
Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China. Open life sciences 2024 4 19 (1): 20220728. Muzhapaer Abudukeremu, Aisikaer Ayoufu, Adila Tuerhong, Xuelaiti Paizula, Jiang-Hua |
- Page last reviewed:Feb 1, 2024
- Content source: